Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Live Streamed
On Demand
Back
320 Views
Favorite
Facebook
Tweet
Print
Session: Clinical Controversies
437 - Fidaxomicin isn't necessary with Vancomycin and Bezlotuxumab: Con
Friday, October 18, 2024
3:33 PM – 3:51 PM
US PT
Location: Concourse 152
Debate Style Speaker(s)
ED
Erik Dubberke, MD, MSPH
Professor of Medicine
Washington University School of Medicine
Disclosure(s):
Erik Dubberke, MD, MSPH
: AstraZeneca: Advisor/Consultant (Ongoing), Grant/Research Support (Ongoing); Ferring: Advisor/Consultant (Ongoing), Grant/Research Support (Ongoing); Merck: Advisor/Consultant (Ongoing); Pfizer: Grant/Research Support (Ongoing); Recursion: Advisor/Consultant (Ongoing); Seres Therapeutics: Advisor/Consultant (Ongoing); Theriva Biologics: Grant/Research Support (Ongoing); Vedanta: Grant/Research Support (Ongoing)
